Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

letter

. 2021 Oct 20;33(1):109–111. doi: 10.1016/j.annonc.2021.10.004

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 Published by Elsevier Ltd on behalf of European Society for Medical Oncology.

Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

PMC Copyright notice

Acute side-effects after vaccination among patients with cancer by (A) Sex: male versus female. (B) Cancer type: solid versus hematologic malignancies. (C) Treatment: B-cell targeted therapy (BCT) versus no BCT. (D) Treatment: immune checkpoint inhibitors (ICI) versus no ICI. (E) Treatment: hormone therapy (HT) versus no HT. (F) Treatment: cytotoxic chemotherapy (CT) versus no CT.